Chinas major health industry and a breakthrough business strategies for functional drinks.docVIP

 PAGE \* MERGEFORMAT 11 China’s major health industry and a breakthrough business strategies for functional drinks After the money do? Dining? Housing? Travel? We had heard a saying: a young man, take healthy exchange for money; old age, take-earned money to buy health. Think about the last dragon Yansheng treasures fluid, three oral solution, the spectrum of the golden age of the treatment instrument, take a look at the moment Melatonin, gold partner, wife, oral, and Coconut Island Deer Tortoise wine a good day. As the Erie milk advertising appeals: Yili milk, the health of your investments every day. Yes, investment in health is that people have money invested after the first. Major health industry, large-scale development opportunities Undoubtedly, the major health industry is the core of the economy in the 21st century industry, is a catalyst for other industries to break this impasse; like the network to be as vast as the impact of various industries. Japan and other countries have major health industry as a key investment target, if the United States rely on the software industry have sprung up everywhere, then who can deny that Japan’s recovery by the ambitions of major health industry do? With the mapping of the human genome deciphered, science and technology leader in the future is not necessarily the big winner, the first application in order to take the lead, but was originally brought on by the Japanese are good at, and its biggest advantage is speed, low cost, profit rich! The moment, the majority consensus is that the pharmaceutical industry will be the twenty-first century gold industry. If the health industry, than doing the whole big sea, an iceberg, then the life-saving pharmaceutical industry is just floating in the sea on the tip of the iceberg, while the rule does not cause disease in health-care Shangju submerged in the underwater part of the largest was even more alarming. Although many domestic pharmaceutical companies have not yet f